BCR-ABL kinase domain mutation analysis in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: recommendations from an expert panel on behalf of European LeukemiaNet.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples